Eighty patients will be included and randomized in two groups, one group (40 patients) will be administered 30 ml of the supplement Carminal, once a day, plus therapy for HP gastitis and the control group (40 patients) will be given standard therapy for HP gastritis with placebo. Treatment will begin after complection of upper endoscopy with histology results from biopted gastric mucosa. Treatment with Carminal will be continued after successful HP eradication during 12 weeks. The final evaluation will take place 12 weeks after the last Carminal intake, when control endoscopy with histology will be performed. The study will last approximately 24 weeks.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Glasgow Dyspepsia Severity Score
Timeframe: Baseline, Week 7 (post-eradication), Week 20 (end of treatment)
Endoscopic assessment of gastric mucosa
Timeframe: Baseline and Week 21
Histological assessment of gastric mucosa
Timeframe: Baseline and Week 21